Celprogen Launches 3D Printed Scaffold Human Heart.
M2 PHARMA-September 21, 2016-Celprogen Launches 3D Printed Scaffold Human Heart
(C)2016 M2 COMMUNICATIONS
- US-based stem cell company Celprogen Inc. has finished printing 3D hearts from flexible Poly Lactic Acid material scaffold that was populated with adult human cardiac stem cells, the company said.
These 3D printed human hearts were coated and seeded with human adult cardiac stem cells.
The 3D scaffold was populated with two T225 human Cardiac Stem Cells 36099-26-T225, and with human adult cardiac cells 36044-15-T225, the scaffold was coated with ECM prior to seeding the cells.
This flexible PLA scaffold allows the seeded cardiac stem cells to potentially contract. The 3D print was reduced from adult 17-year-old heart to 1/3 its original size.
The present invention relates to 3D organ printing programs at Celprogen that identifies potential future use in transplant of major organ systems. At present, Celprogen is validating the 3D human printed heart from flexible PLA.
Celprogen is developing a proprietary portfolio of therapeutics products and life science research tools that includes genetic engineering technologies, stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue and organ transplants.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Sep 21, 2016|
|Previous Article:||Spirox Shows Positive Results from Latera Implant Study in Nasal Valve Collapse Patients.|
|Next Article:||BioArctic partners with AbbVie for research in parkinson's disease.|